Providence Therapeutics

Calgary, ALBERTA

Providence Therapeutics is a private Canadian biotechnology company that specializes in messenger RNA (mRNA) vaccine therapies.
We hold deep expertise in the science of mRNA with operations located in Calgary, Alberta and Toronto, Ontario. The beginnings of Providence Therapeutics started with our undivided focus on oncology research and personalized cancer therapies. However, given the global COVID-19 crisis, we have pivoted from our original mission, devoting our energy, knowledge, and resources to creating a world-class mRNA COVID-19 vaccine, which is currently under Phase 2 Human Clinical Trial.

?>